Status:
UNKNOWN
Clinical Outcomes of Laser Prostatectomy
Lead Sponsor:
National Taiwan University
Conditions:
Prostatic Hypertrophy
Eligibility:
MALE
50+ years
Phase:
NA
Brief Summary
Benign prostate obstruction (BPO) can be treated with a range of laser treatments using different laser systems and applications. Transurethral laser treatment is considered to be an alternative treat...
Detailed Description
80 patients with symptomatic benign prostate obstruction (BPO) will be assigned under randomization to treat with GreenLight laser or thulium laser. Randomization is performed by free randomization so...
Eligibility Criteria
Inclusion
- Inclusion criteria are patient age greater than 50 years, maximum flow rate (Qmax) \< 15 ml/second and an International Prostate Symptom Score (IPSS) ≥ 10.
Exclusion
- Exclusion criteria are known prostate cancer, bladder cancer, previous transurethral surgery, interstitial cystitis and neurogenic bladder confirmed after urodynamic studies.
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03318991
Start Date
October 1 2017
End Date
November 30 2019
Last Update
August 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New Taipei City Hospital
New Taipei City, Taiwan